Where can I find ruxolitinib/ruxolitinib cream? Purchase channels revealed!

Ruxolitinib cream is a topical drug developed by Incyte. It is mainly used to treat skin diseases caused by immune system abnormalities, especially in the treatment of immune-mediated skin diseases such as atopic dermatitis (AD) and vitiligo. The pharmacological mechanism of ruxolitinib ointment is to reduce skin inflammation and relieve skin symptoms caused by overactive immune responses by locally inhibiting the JAK-STAT signaling pathway. Because the JAK-STAT pathway plays a key role in immune cell activity and inflammatory responses, ruxolitinib can effectively reduce symptoms such as skin inflammation, itching, and redness.

In the treatment of atopic dermatitis, ruxolitinib ointment can alleviate the patient's skin inflammatory response and reduce the possible side effects of long-term use of steroid drugs. Research shows that compared with traditional steroid drugs, ruxolitinib ointment is equally effective in efficacy, but has relatively few side effects, especially when used for a long time, it can avoid problems such as skin thinning.

However, it is worth noting that ruxolitinib ointment has not yet been officially launched in mainland China, so many patients need to purchase this drug through overseas channels. For patients who need to use ruxolitinib ointment, there are two common ways to purchase it: one is through overseas purchasing, and the other is through international pharmaceutical e-commerce platforms.

In general, ruxolitinib ointment, as a new type of immunosuppressive topical treatment, has significant therapeutic effects on skin diseases such as atopic dermatitis and psoriasis. Although it is not yet available in mainland China and patients can purchase it through overseas channels, when choosing a purchasing channel, special attention should be paid to the legality and safety of the source of the drug to ensure the effectiveness and safety of the treatment.

Reference: https://www.opzelura.com/